1. Modifying Disease Course in Alzheimer's Disease

2. Program Goals

3. Alzheimer's Disease Overview

4. The Importance of Early Diagnosis

5. Assessing a Patient's Clinical History

6. Cognitive Testing in Alzheimer's Disease

7. Genetic and Laboratory Testing

8. Genetic and Laboratory Testing (cont)

9. Standard Neuroimaging

10. Additional Neuroimaging

11. Is Prevention Possible?

12. Assessing Risk Factors

13. AD Prevention Trials: Early-Onset AD

14. Late-Onset AD Prevention Trial: A4

15. Late-Onset AD Prevention Trial: TOMORROW

16. Late-onset AD Prevention Trial: API APOE

17. Multimodal Interventions

18. Nutritional Interventions in AD and MCI

19. Dietary Ketosis in MCI

20. Medium-Chain Triglycerides in AD

21. Alzheimer's Disease Cooperative Study: DHA as AD Treatment

22. The Role of Omega 3s in AD Prevention

23. B Vitamins and AD

24. Cholinesterase Inhibitor Add-Ons

25. Flavinoids and AD

26. Coffee and AD

27. Cognitive Intervention

28. Treating AD Symptoms

29. Anti-Tau Antibodies

30. Anti-Hyperglycemic Therapy: SNIFF 120 Study

31. Anti-Aβ Therapies

32. Anti-Aβ Therapies (cont)

33. BACE Inhibitors: Verubecestat

34. Conclusions

35. Abbreviations

36. Abbreviations (cont)